Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Titel:
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Auteur:
Moore, K.N. Oza, A.M. Colombo, N. Oaknin, A. Scambia, G. Lorusso, D. Konecny, G.E. Banerjee, S. Murphy, C.G. Tanyi, J.L. Hirte, H. Konner, J.A. Lim, P.C. Prasad-Hayes, M. Monk, B.J. Pautier, P. Wang, J. Berkenblit, A. Vergote, I. Birrer, M.J.